Shumway Capital is a growth focused investment firm that partners with management teams to help accelerate their companies’ growth.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 28 Havemeyer Place
City: Greenwich
State: CT
Zip: 06830
Country: US
Shumway Capital is an investment firm that uses a unique growth-focused investment model. As entrepreneurs themselves, the investment team has first-hand knowledge of how to help other companies accelerate their growth and realize their specific visions. The firm’s partners invest their own capital and provide a permanent capital base for their investments. They focus on high-growth businesses across a wealth of industries and have a collaborative approach that enables the management team and the company to continue operating their business effectively without any disruption.
Contact Phone:
+12034858550
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2016 | Elligo Health Research | Series A | - |
3/2018 | Finch Therapeutics | Series B | 0 |
5/2019 | Vedanta Biosciences | Series C | 18.5M |
8/2019 | Finch Therapeutics | Series C | 0 |
3/2015 | Trumid | Series A | 8.3M |
7/2017 | Artsy | Series D | 0 |
9/2020 | Finch Therapeutics | Series D | 0 |
3/2018 | Elligo Health Research | Series B | 0 |
9/2021 | Elligo Health Research | Series E | 0 |
5/2019 | Elligo Health Research | Series C | 0 |
7/2021 | Vedanta Biosciences | Series D | 0 |
9/2021 | Elligo Health Research | Series E | 0 |
7/2021 | Vedanta Biosciences | Series D | 0 |
9/2020 | Finch Therapeutics | Series D | 0 |
8/2019 | Finch Therapeutics | Series C | 0 |
5/2019 | Vedanta Biosciences | Series C | 0 |
5/2019 | Elligo Health Research | Series C | 0 |
3/2018 | Elligo Health Research | Series B | 0 |
3/2018 | Finch Therapeutics | Series B | 0 |
7/2017 | Artsy | Series D | 0 |
3/2016 | Elligo Health Research | Series A | - |
Name | Price |
---|
Name | Size | Announced Date |
---|